X-Pure®: A world-class range of customizable low-endotoxin gelatins and collagens for in vitro and in vivo applications
X-Pure® is a range of low-endotoxin, customizable, pharmaceutical-grade gelatins designed to ensure maximum quality and safety. The range comprises various gelatins and modified gelatins, namely X-Pure, X-Pure GelMA, and X-Pure GelDAT. Notably X-Pure GelMA is the world’s first gelatin methacryloyl produced under GMP conditions.
The ultra-purified and modified gelatins within the X-Pure range find application in diverse fields such as regenerative medicine, drug delivery, embolization, and hemostasis projects.
New Quali-Pure® range of pharmaceutical gelatins
Specifically designed to support biomedical application areas including embolization, wound healing, drug delivery, vaccines and hemostatics, Quali-Pure® delivers biocompatibility, biodegradability, controlled endotoxin levels, and batch-to-batch consistency.
All Rousselot biomedical gelatins are GMP* ready and fully documented to support medical device compliance with ISO standards and the new EU Medical Device Regulation (MDR).
Rousselot’s research and GMP grades are functionally equivalent, streamlining the transition from research to clinical trials by minimizing the necessity for data revalidation.
Rousselot Biomedical is committed to engineering, accelerating and scaling superior products to help transform ideas into biomedical solutions worldwide, using our scientific expertise and collaborative approach to support end-to-end partnerships and to “Improve patients’ lives”.
* IPEC & PQG Joint Good Manufacturing Practices Guide for Pharmaceutical Excipients
Rousselot BV
Kanaaldijk Noord 20
5691 NM SON
The Netherlands
Phone: +31 499 364100
For more information please visit: www.rousselot.com/biomedical
